Wagstaff, J., Sternberg, C. N., Hawkins, R. E., Salman, P., Mardiak, J., Barrios, C. H., . . . Davis, I. D. (2013). A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: Final overall survival results and safety update. European Journal of Cancer, 49(6), pp. 1287-1296. doi:10.1016/j.ejca.2012.12.010

Wagstaff, John, et al. "A Randomised, Double-blind Phase III Study of Pazopanib in Patients With Advanced And/or Metastatic Renal Cell Carcinoma: Final Overall Survival Results and Safety Update." European Journal of Cancer 49, no. 6 (2013): 1287-1296.

Wagstaff, John, et al. "A Randomised, Double-blind Phase III Study of Pazopanib in Patients With Advanced And/or Metastatic Renal Cell Carcinoma: Final Overall Survival Results and Safety Update." European Journal of Cancer 49.6 (2013): 1287-1296.